Empowering Healthcare with Innovation
Cabot's cutting-edge healthcare IT solutions provide actionable insights that empower our clients to excel in the competitive healthcare landscape
https://www.cabotsolutions.com/healthcare-software-development-solutions
#HealthcareInnovation #HealthIT #DigitalHealth #HealthcareAI #DataDrivenCare #HealthTechSolutions #ClinicalInsights #HealthcareAnalytics #CabotSolutions #FutureOfHealthcare
Objective: This study aimed to evaluate whether three popular chatbots powered by large language models (LLMs)—ChatGPT, Claude, and Gemini—provided direct responses to suicide-related queries and how these responses aligned with clinician-determined risk levels for each question. Methods: Thirteen clinical experts categorized 30 hypothetical suicide-related queries into five levels of self-harm risk: very high, high, medium, low, and very low. Each LLM-based chatbot responded to each query 100 times (N=9,000 total responses). Responses were coded as “direct” (answering the query) or “indirect” (e.g., declining to answer or referring to a hotline). Mixed-effects logistic regression was used to assess the relationship between question risk level and the likelihood of a direct response. Results: ChatGPT and Claude provided direct responses to very-low-risk queries 100% of the time, and all three chatbots did not provide direct responses to any very-high-risk query. LLM-based chatbots did not meaningfully distinguish intermediate risk levels. Compared with very-low-risk queries, the odds of a direct response were not statistically different for low-risk, medium-risk, or high-risk queries. Across models, Claude was more likely (adjusted odds ratio [AOR]=2.01, 95% CI=1.71–2.37, p<0.001) and Gemini less likely (AOR=0.09, 95% CI=0.08–0.11, p<0.001) than ChatGPT to provide direct responses. Conclusions: LLM-based chatbots’ responses to queries aligned with experts’ judgment about whether to respond to queries at the extremes of suicide risk (very low and very high), but the chatbots showed inconsistency in addressing intermediate-risk queries, underscoring the need to further refine LLMs.
How to Market to Nurse Practitioners in Pharma
https://www.engagenovem.com/how-to-market-to-nurse-practitioners-in-pharma
Integrating clinical knowledge with medical knowledge
For healthcare professionals to provide patient-centered, evidence-based care, they need to keep abreast with the latest clinical research and insights. Physicians, nurses, and other allied healthcare providers need to engage in ongoing learning due to new and changing research, technology, and treatment
#ClinicalInsights #HealthcareProfessionals #MedicalEducation
I'm the Chief Scientist in the #ClinicalInsights & #Innovation Cell at #MITRE
Before that I was the Director of #DataScience and #MedicalInformatics at Pfizer, leading #DigitalHealth efforts in #DigitalBiomarkers, #DecentralizedTrials, and #AI #ML algorithm development, as well as the co-PI for multiple #ClinicalTrials evaluating #wearables.
My interests for hashtag discovery:
#ArtificialIntelligence #MachineLearning #Bioinformatics #Genomics #RealWorldEvidence #HealthCare
cabot
RE.DOCTOR
🌎 Experiencia interdimensional
Tomasz Adamusiak 🇺🇦